Twin Tree Management, LP Acadia Pharmaceuticals Inc Transaction History

Twin Tree Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$17.79 - $30.86 $1.37 Million - $2.37 Million	76,887 New	76,887 $1.42 Million
Q1 2020 May 13, 2020	SELL	$31.65 - $46.87 $37,125 - $54,978	-1,173 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $42,474 - $60,292	1,173 New	1,173 $50,000
Q2 2019 Aug 12, 2019	SELL	$23.32 - $28.12 $25,465 - $30,707	-1,092 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$16.17 - $27.38 $17,657 - $29,898	1,092 New	1,092 $29,000

280

156M

901K

314K

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.65B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

Stay updated on Twin Tree Management, LP with notifications on news.